Issue 4 march 2016 Special Report Intestinal Microbiota, Obesity, and Associated Metabolic Disorders
The many studies conducted on microbiota in recent years have shown how important they are for our physiology and how issues with microbiota play a role in many diseases. We owe this plethora of studies to the work of Jeffrey Gordon and his team who showed a decade ago that mice without gut microbiota had less adipose tissue and that obese individuals had different microbiota than thin individuals.
Thus, the hypothesis that gut microbiota could be involved in obesity came to be. Numerous studies have since confirmed the contribution of gut microbiota to obesity and its metabolic comorbidities such as type 2 diabetes and fatty liver disease. This issue aims to take stock of this topical subject, given the growing prevalence of these conditions and the hope of developing targeted treatments of the gut microbiota.
Table of contents
- The Non-Selective Effect of Selective Digestive DecontaminationBruno Pot
- Diverticulitis: Gut Microbiota Not ResponsibleBruno Pot
- Microbiota of the Meconium: The Earliest Gut MicrobiotaAlexis Mosca
- Faecal Microbiota Transplantation and IBS with BloatingStanislas Bruley des Varannes
- Benefits of Early Probiotic Supplements for Children to Limit the Risk of Developing an AllergyJean-Marc Bohbot
- Gut Microbiota and HIVJacques Amar
The Microbiota Chronicle
- Can PPIs be Widely Used Without Risk for the Gut Microbiota?Stanislas Bruley des Varannes
- Patrice D. Cani
EntretienPr Patrice D. Cani
Louvain Drug Research Institute, Metabolism and Nutrition, Walloon Excellence in Life sciences and BIOtechnology (WELBIO), NeuroMicrobiota lab, European Associated Laboratory (INSERM/UCL), Bruxelles